Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Tuberculosis Diagnostics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The tuberculosis diagnostics market has seen significant growth in recent years. This market is set to expand from $2.34 billion in 2025 to $2.52 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.9%. The increase observed in prior periods can be attributed to the worldwide tuberculosis disease burden, the broadening of public health screening initiatives, the availability of smear microscopy infrastructure, international funding directed towards TB control, and the adoption of culture-based diagnostics.
The tuberculosis diagnostics market is anticipated to experience significant expansion in the coming years, with its valuation projected to reach $3.37 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This projected increase is driven by factors such as the heightened need for swift and precise TB diagnosis, an intensified emphasis on detecting drug-resistant TB, the proliferation of decentralized diagnostic solutions, increased financial commitments to molecular diagnostics, and the incorporation of AI-powered diagnostic instruments. Key developments expected during this timeframe involve the wider acceptance of molecular TB testing approaches, the increasing utilization of rapid diagnostic platforms, the broader incorporation of drug resistance identification, the spread of point-of-care TB testing, and a stronger emphasis on diagnostics offering high sensitivity.
Get A Free Sample Report With In-Depth Market Insights:
Tuberculosis Diagnostics Market Growth Catalysts And Demand Drivers
The increasing occurrence of tuberculosis is propelling the demand within the tuberculosis diagnostics market in the future. Tuberculosis (TB), a contagious bacterial infection mainly affecting the lungs, necessitates prompt identification to avert serious complications and its spread. The escalation in TB incidence stems from the growing prevalence of HIV/AIDS, which significantly weakens the immune system, rendering individuals highly vulnerable to active tuberculosis. This heightened incidence of tuberculosis consequently supports the tuberculosis diagnostics sector by stimulating the need for swift, precise, and point-of-care diagnostic tests, facilitating early treatment and improved disease management. For example, in October 2025, the UK Health Security Agency, a government body overseeing health security in England, reported that Tuberculosis levels in England rose by 13.6 percent in 2024 compared with 2023, with 5,490 notifications documented in 2024 versus 4,831 in 2023. Thus, the growing incidence of tuberculosis is fostering the expansion of the tuberculosis diagnostics market.
Tuberculosis Diagnostics Market Breakdown By Product Type And Application
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
Tuberculosis Diagnostics Market Trends Shaping Long-Term Demand
Leading companies in the tuberculosis diagnostics market are concentrating on product innovations and developing new diagnostic solutions, such as tuberculosis diagnostic tests, to strengthen their market presence. Tuberculosis diagnostic tests refer to medical examinations and laboratory techniques employed to determine if an individual is infected with Mycobacterium tuberculosis, the bacteria responsible for TB. These tests are instrumental in identifying active TB disease, latent TB infection, and drug-resistant strains, enabling the prompt initiation of appropriate treatment. For instance, in February 2023, Redcliffe Labs, an India-based technology-driven diagnostics service provider, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test allows clinicians to rapidly screen for tuberculosis and multidrug resistance as a first-line test, performed on the BD MAX molecular diagnostic system. Clinicians utilize this test to simultaneously detect the bacteria causing TB and ascertain whether they carry mutations linked to resistance to two crucial first-line drugs, Isoniazid (INH) and Rifampicin (RIF).
Tuberculosis Diagnostics Market Leading Players And Competitive Positioning
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio
View The Full Tuberculosis Diagnostics Market Report:
Tuberculosis Diagnostics Market Regional Split: Which Areas Are Fueling Growth?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
